Guidance

Principles for control of non-HCID mpox in the UK: 4 nations consensus statement

A consensus statement outlining principles for the control of non-high-consequence infectious disease (HCID) mpox (monkeypox) in healthcare and other settings in the UK.

• From: UK Health Security Agency, Public Health Wales and Public Health Agency (Northern Ireland)
• Published: 30 May 2022
• Last updated: 31 October 2024
  Show all updates

  1. 31 October 2024

     Minor update to reflect the first detection of clade I mpox in the UK.

  2. 27 September 2024

     Updated links to direct to the Green Book chapter 29.

  3. 25 January 2023

     Updated in line with HCID derogation of Clade II MPXV (monkeypox virus). Added new section on cleaning and decontamination.

  4. 5 January 2023

     Updated strategic aims.

  5. 3 November 2022

     Updated text about evidence of pre-symptomatic transmission.

  6. 21 September 2022

     Updated to reflect the change in monkeypox clade nomenclature.

  7. 25 July 2022

     Amended in line with introduction of highly probable case definition.

  8. 19 July 2022

     Updated to reflect changes in management of contacts of a confirmed case of monkeypox.

  9. 15 July 2022

     Updated guidance, including information on using a condom after recovering from infection.

  10. 5 July 2022

      Updated to reflect HCID derogation of the current outbreak of monkeypox, and changes to active monitoring of contacts.

  11. 30 May 2022

      First published.

This publication was withdrawn on 25 March 2025

The information in this document was superseded by the ‘Biological principles for control of mpox in the UK: 4 nations consensus statement’.

Documents

Principles for control of non-HCID mpox in the UK: 4 nations consensus statement

HTML

Details

This document outlines strategic aims for controlling non-HCID mpox, assumptions about mpox transmission and biology, and implications for domestic/community, ambulatory care, inpatient healthcare and other residential settings.

This statement has been agreed by the UK public health agencies: UK Health Security Agency, Public Health Scotland, Public Health Wales and Public Health Agency Northern Ireland.